// App-Quantinova.ai

231 : Clinical Risk Factors for Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant Recipients (LTRs): Results of an International Cohort Study.

Researchers

Presenter

  • N. Law

Principal Investigators

  • B. Hamandi

  • C. Fegbeutel

  • F. Silveira

  • E. Verschuuren

  • P. Ussetti

  • P. Chin-Hong

  • A. Sol

  • C.-L. Holmes-Liew

  • E. Billaud

  • P. Grossi

  • O. Manuel

  • D. Levine

  • R. Barbers

  • D. Hadjiliadis

  • L. Singer

  • S. Husain

Medical Centers

  • Universtiy Health Network, Toronto, ON, Canada

  • Hannover Medical School, Hannover, Germany

  • University of Pittsburgh, Pittsburgh, PA

  • University Medical Center, University of Groningen, Groningen, Netherlands

  • Hospital Puerta de Hierro, Madrid, Spain

  • University of California, San Francisco, CA

  • University and Polytechnic Hospital La Fe, Universidad de Valencia, Valencia, Spain

  • Royal Adelaide Hospital, Adelaide, Australia

  • APHP Hopital Européen G Pompidou, Paris, France

  • Univ. of Insubria, Varese, Italy

  • University Hospital Vaud, Lausanne, Switzerland

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • KECK Medical Center of University of Southern California, Los Angeles, CA

  • University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, PA

Locations

  • Canada

  • Germany

  • United States

  • Netherlands

  • Spain

  • Australia

  • France

  • Italy

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved